• No results found

Design considerations for early-phase clinical trials of immune-oncology agents

N/A
N/A
Protected

Academic year: 2020

Share "Design considerations for early-phase clinical trials of immune-oncology agents"

Copied!
10
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1 Design challenges, recommendations, assumptions, and available software for early-phase trials of imunne-oncology agents

References

Related documents

Phytoconstituents present in Commiphora berryi were flavonoids, glycosides, reducing sugar, saponins, steroids, starch, tannins and terpenoids; amino acids, flavonoids,

Aspergillosis is a threat of holding kiwi in captivity. No research has previously looked at the background levels of Aspergillus in kiwi houses. In this study we found A.

Thermal Aging ASTM D2671 750 hours at 150°C (302°F), which is a useful indicator of life expectancy and ties the material’s tested performance attributes to a service life of 30

Furthermore, when the temperature increased further, the kinetic energies of henna extract molecules became higher than the potential attractive forces of the

The state energy policy strategic objective set to form a rational fuel and energy balance is to optimize the production, domestic consump- tion and export of fuel and energy

Finally, for the flexible approaches, we analyze three different ways how to define the reference market price, which determines the water fee level: The yearly average

It was a cross-sectional descriptive study carried out in the Department of Pediatric Gastroenterology & Nutrition, Bangabandhu Sheikh Mujib Medical University, Dhaka from